Vitamin D deficiency and type 2 diabetes

Postgraduate Medical Journal

Volumn 86, Issue 1011, 2010, Pages 18-25

  Ozfirat, Zehra ^a   Chowdhury, Tahseen A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 7 DEHYDROCHOLESTEROL; ADIPONECTIN; C REACTIVE PROTEIN; CALCITRIOL; CALCIUM; CITRATE CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; FIBRINOGEN; GELATINASE B; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 6; ORAL ANTIDIABETIC AGENT; OROSOMUCOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PLASMINOGEN ACTIVATOR INHIBITOR; SIALIC ACID; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

BETEL NUT; BODY MASS; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CAUCASIAN; CELL FUNCTION; CLINICAL TRIAL; CLOTHING; DISEASE ASSOCIATION; DRUG MEGADOSE; EATING HABIT; ETHNICITY; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; GLYCEMIC CONTROL; HUMAN; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; LATITUDE; LIFESTYLE; LOW DRUG DOSE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PHYSICAL ACTIVITY; REVIEW; RISK ASSESSMENT; SEASONAL VARIATION; SUBSTITUTION THERAPY; SUMMER; SUN EXPOSURE; ULTRAVIOLET B RADIATION; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WINTER;

DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGIC METHODS; HUMANS; INSULIN RESISTANCE; SEASONS; VITAMIN D DEFICIENCY;

EID: 74749104899     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2009.078626     Document Type: Review

References (75)

1. Roglic G, Unwin N, Bennett PH, et al. The burden of mortality attributable to diabetes realistic estimates for the year 2000. Diabetes Care 2005;28:2130-5.
2. Riste L, Khan F, Cruickshank K. High prevalence of type 2 diabetes in all ethnic groups, including Europeans, in a British inner city: relative poverty, history, inactivity, or 21st century Europe? Diabetes Care 2001;24:1377-83.
3. Christakos S, Friedlander EJ, Frandsen BR, et al. Studies on the mode of action of calciferol. XIII. Development of a radioimmunoassay for vitamin D-dependent chick intestinal calcium-binding protein and tissue distribution. Endocrinology 1979;104:1495-503.
4. Norman AW, Frankel JB, Heldt AM, et al. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980;209:823-5.
5. Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 2008;93:512-17.
6. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-11.
7. Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006;98:451-9.
8. Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome 'X'? Br J Nutr 1998;79:315-32.
9. Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-29.
10. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
11. Bandeira F. Vitamin D deficiency: a global perspective. Arq Bras Endocrinol Metabol 2006;50:640-6.
12. Mishal AA. Effects of different dress styles on vitamin D levels in healthy young Jordanian women. Osteoporos Int 2001;12:931-5.
13. Holvik K, Meyer HE, Haug E, et al. Prevalence and predictors of vitamin D deficiency in five immigrant groups living in Oslo, Norway: the Oslo Immigrant Health Study. Eur J Clin Nutr 2005;59:57-63.
14. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-3.
15. Ogunkolade WB, Boucher BJ, Bustin SA, et al. Vitamin D metabolism in peripheral blood mononuclear cells is influcenced by chewing "betel nut" (Areca catechu) and vitamin D status. J Clin Endocrinol Metab 2006;91:2612-17.
16. Deluca HF, Catorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001;15:2579-85.
17. Cantorna MT, Zhu Y, Froicu M, et al. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004;80:1717S-20S.
18. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80:1678S-88S.
19. Van Driel ML, Koedam M, Buurman CJ, et al. Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells. FASEB J 2006;20:2417-19.
20. Pols HA, Birkenhager JC, Foekens JA, et al. Vitamin D: a modulator of cell proliferation and differentiation. J Steroid Biochem Mol Biol 1990;37:873-6.
21. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770-3.
22. Mathieu C, Gysemans C, Guilietti A, et al. Vitamin D and diabetes. Diabetologia 2005;48:1247-57.
23. Bland R, Markovic D, Hills CE, et al. Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 2004;89:121-5.
24. Milner RD, Hales CD. The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia 1967;3:47-9.
25. Chiu KC, Chu A, Go VL, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-5.
26. Gedik O, Akalin S. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 1986;29:142-5.
27. Wright DC, Hucker KA, Holloszy JO, et al. Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes 2004;53:330-5.
28. Ojuka EO. Role of calcium AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle. Proc Nutr Soc 2004;63:275-8.
29. Maestro B, Molero S, Bajo S, et al. Transcriptional activation of the human insulin receptor gene by 1, 25-dihydroxyvitamin D(3). Cell Biochem Funct 2002;20:227-32.
30. Maestro B, Campion J, Davila N, et al. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 2000;47:383-91.
31. Dunlop TW, Vaisanen S, Frank C, et al. The human peroxisome proliferator activated receptor δ gene is a primary target of 1alpha, 25-dihydroxyvitamin d3 and its nuclear receptor. J Mol Biol 2005;349:248-60.
32. Tanaka T, Yamamoto J, Iwasaki S, et al. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 2003;100:15924-9.
33. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116:1793-801.
34. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin-6 and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.
35. Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003;52:1799-805.
36. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 2003;46:1594-603.
37. Hotamisligil GS, Budavari A, Murray D, et al. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 1994;94:1543-9.
38. Senn JJ, Klover PJ, Nowak IA, et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem 2003;278:13740-6.
39. Gysemans CA, Cardozo AK, Callewaert H, et al. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in non-obese diabetic mice. Endocrinology 2005;146:1956-64.
40. Kadowaki S, Norman AW. Pancreatic vitamin D-dependent calcium binding protein: biochemical properties and response to vitamin D. Arch Biochem Biophys 1984;233:228-36.
41. Timms PM, Mannan N, Hitman GA, et al. Circulating MMP-9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 2002;95:787-96.
42. Doro P, Benko R, Matuz M, et al. Seasonality in the incidence of type 2 diabetes: a population-based study. Diabetes Care 2006;29:173.
43. Scragg R, Sowers MF, Bell C. Serum 25-hydroxyvitamin D, diabetes and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004;27:2813-18.
44. Hypponen E, Boucher BJ, Berry DJ, et al. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross sectional study in the 1958 British Birth Cohort. Diabetes 2008;57:298-305.
45. Boucher BJ, Mannan N, Noonan K, et al. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians. Diabetologia 1995;38:1239-45.
46. Scragg R, Holdaway I, Singh V, et al. Serum 25-hydroxyvitamin Ds levels decreased in IGT and diabetes. Diabetes Res Clin Pract 1995;27:181-8.
47. Need AG, O'Loughlin PD, Horowitz M, et al. Relationship between fasting serum glucose, age, body mass index and serum 25-hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf) 2005;62:738-41.
48. Baynes KC, Boucher BJ, Feskens EJ, et al. Vitamin D glucose tolerance and insulinaemia in elderly men. Diabetologia 1997;40:344-7.
49. Mattila C, Laaksonen MA, Knekt P, et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 2007;30:2569-70.
50. Pittas AG, Willett WC, Dawson-Hughes B, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006;29:650-6.
51. Liu S, Klevak A, Choi HK, et al. A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care 2006;29:1579-84.
52. Choi HK, Willett WC, Stampfer MJ, et al. Dairy consumption and risk of type 2 diabetes mellitus in men. Arch Intern Med 2005;165:997-1003.
53. Fourohi NG, Luan J, Cooper A, et al. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008;57:2619-25.
54. Knekt P, Laaksonen M, Mattila C, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008;19:666-71.
55. Cigolini M, Galiotto M, Iagulli MP, et al. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 2006;29:722-3.
56. Targher G, Bertolini L, Padovani R, et al. Serum 25-hydroxyvitamin D3 concentrations and carotid intima media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 2006;65:593-7.
57. Aksoy H, Akcay F, Kurtul N, et al. Serum 1,125 dihyroxy vitamin D (1,25 (OH)2 D3), 25 Hydroxyvitamin D (25(OH)D) and parathormone levels in diabetic retinopathy. Clin Biochem 2000;33:47-51.
58. Ogunkolade BW, Boucher BJ, Prahl JM, et al. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to Vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002;51:2294-300.
59. Hitman GA, Mannan N, McDermott MF, et al. Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes 1998;47:688-90.
60. Oh JY, Barrett Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 2002;51:356-9.
61. Ortlepp JR, Metrikat J, Albrecht M, et al. The vitamin D receptor gene variants and physical activity predicts fasting glucose levels in healthy young men. Diabet Med 2003;20:451-4.
62. Baier LJ, Dobberfuhl AM, Pratley RE, et al. Variations in Vitamin D binding protein (Gc locus) are associated with oral glucose tolerance in non-diabetic Pima Indians. J Clin Endocrinol Metab 1998;83:2993-6.
63. de Souza Santos R, Vianna LM. Effect of cholecalciferol supplementation on blood glucose in an experimental model of Type 2 diabetes mellitus in spontaneously hypertensive and Wistar rats. Clin Chim Acta 2005;358:146-50.
64. Zemel MB, Donnelly JE, Smith BK, et al. Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res 2004;12:582-9.
65. Borissova AM, Tankova T, Kirilov G, et al. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003;57:258-61.
66. Orwoll E, Riddle M, Prince M. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1994;59:1083-7.
67. Pittas AG, Harris SS, Stark PC, et al. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in non-diabetic adults. Diabetes Care 2007;30:980-6.
68. de Boer IH, Tinker LF, Connelly S, et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Womens Health Initiative. Diabetes Care 2008;31:701-7.
69. Geleijnse JM. Vitamin D and hypertension: does the women's health initiative solve the question? Hypertension 2008;52:803-4.
70. Armas LAG, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004;89:5387- 91.
71. Holick MF, Biancuzzo RM, Chen TC, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008;93:677-81.
72. Hippisley-Cox J, Coupland C, Robson J, et al. Predicting the risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDS score. BMJ 2009;338:b880.
73. Knowler WC, Barrett-Connor PH, Fowler SE, et al. Reduction in the incidence of type 2 Diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
74. Laaksonen DE, Lindstrom J, Lakka TA, et al. Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes 2005;54:158-65.
75. Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 2001;24:1496.